Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes

被引：0
|
作者：
Matthews, David R. [1 ]
机构：
[1] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
DIABETES OBESITY & METABOLISM | 2024年 / 26卷
关键词：
canagliflozin; cardiovascular disease; heart failure; SGLT2; inhibitor; CARDIOVASCULAR OUTCOMES;
D O I：
10.1111/dom.15963
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [1] An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
    Hsia, Daniel S.
    Grove, Owen
    Cefalu, William T.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (01) : 73 - 79
  • [2] Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus
    Washburn, William N.
    Poucher, Simon M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (04) : 463 - 486
  • [3] Sodium-glucose co-transporter-2 inhibitors in Type 1 Diabetes: A Scoping Review
    Hropot, Tim
    Battelino, Tadej
    Dovc, Klemen
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 620 - 630
  • [4] Sodium-glucose co-transporter-2 inhibitors and the risk of fractures in patients with type 2 diabetes
    Schmedt, Niklas
    Andersohn, Frank
    Walker, Jochen
    Garbe, Edeltraut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 454 - 454
  • [5] Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?
    Czupryniak, Leszek
    Danne, Thomas
    Szymanska-Garbacz, Elektra
    Zozulinska-Ziolkiewicz, Dorota
    Gumprecht, Janusz
    Klupa, Tomasz
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 764 - 765
  • [6] Sodium-glucose co-transporter-2 inhibitors in the treatment of diabetes with heart failure COMMENT
    Liang, Bo
    Gu, Ning
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [7] Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men
    Radholm, Karin
    Zhou, Zien
    Clemens, Kristin
    Neal, Bruce
    Woodward, Mark
    DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 263 - 266
  • [8] Renal sodium-glucose co-transporter-2 inhibitors: a new treatment option for treatment of diabetes mellitus
    Escalada San Martin, F. J.
    Salvador Rodriguez, F. J.
    AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 449 - 451
  • [9] Renal sodium-glucose co-transporter-2 inhibitors: a new treatment option for treatment of diabetes mellitus
    Escalada San Martin, F. J.
    Salvador Rodriguez, F. J.
    AVANCES EN DIABETOLOGIA, 2010, 26 (05): : 370 - 372
  • [10] Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes
    Sharma, M. D.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 616 - 621
12345